The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Broadly Neutralizing Human Anti-HIV Antibody 2G12 Is Effective in Protection against Mucosal SHIV Challenge Even at Low Serum Neutralizing Titers
Open accessAbstract
Developing an immunogen that elicits broadly neutralizing antibodies (bNAbs) is an elusive but important goal of HIV vaccine research, especially after the recent failure of the leading T cell based HIV vaccine in human efficacy trials. Even if such an immunogen can be developed, most animal model studies indicate that high serum neutralizing concentrations of bNAbs are required to provide significant benefit in typical protection experiments. One possible exception is provided by the anti-glycan bNAb 2G12, which has been reported to protect macaques against CXCR4-using SHIV challenge at relatively low serum neutralizing titers. Here, we investigated the ability of 2G12 administered intravenously (i.v.) to protect against vaginal challenge of rhesus macaques with the CCR5-using SHIV(SF162P3). The results show that, at 2G12 serum neutralizing titers of the order of 1:1 (IC(90)), 3/5 antibody-treated animals were protected with sterilizing immunity, i.e. no detectable virus replication following challenge; one animal showed a delayed and lowered primary viremia and the other animal showed a course of infection similar to 4 control animals. This result contrasts strongly with the typically high titers observed for protection by other neutralizing antibodies, including the bNAb b12. We compared b12 and 2G12 for characteristics that might explain the differences in protective ability relative to neutralizing activity. We found no evidence to suggest that 2G12 transudation to the vaginal surface was significantly superior to b12. We also observed that the ability of 2G12 to inhibit virus replication in target cells through antibody-mediated effector cell activity in vitro was equivalent or inferior to b12. The results raise the possibility that some epitopes on HIV may be better vaccine targets than others and support targeting the glycan shield of the envelope.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells
Geijtenbeek, T. B. H., Kwon, D. S., Torensma, R., van Vliet, S. J., van Duijnhoven, G. C. F., Middel, J., Cornelissen, I. L. M. H. A., Nottet, H. S. L. M., KewalRamani, V. N., Littman, D. R., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)80694-7 · Cited by 2,447
Mascola, J. R., Stiegler, G., VanCott, T. C., Katinger, H., Carpenter, C. B., Hanson, C. E., Beary, H., Hayes, D., Frankel, S. S., Birx, D. L., et al. (2000) · Nature Medicine · doi:10.1038/72318 · Cited by 1,250
Rapid evolution of the neutralizing antibody response to HIV type 1 infection
Richman, D. D., Wrin, T., Little, S. J., & Petropoulos, C. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0630530100 · Cited by 1,200
Trkola, A., Purtscher, M., Muster, T., Ballaun, C., Buchacher, A., Sullivan, N., Srinivasan, K., Sodroski, J., Moore, J. P., & Katinger, H. (1996) · Journal of Virology · doi:10.1128/jvi.70.2.1100-1108.1996 · Cited by 1,114
Li, M., Gao, F., Mascola, J. R., Stamatatos, L., Polonis, V. R., Koutsoukos, M., Voss, G., Goepfert, P., Gilbert, P., Greene, K. M., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.16.10108-10125.2005 · Cited by 1,070
Fc receptor but not complement binding is important in antibody protection against HIV
Hessell, A. J., Hangartner, L., Hunter, M., Havenith, C. E. G., Beurskens, F. J., Bakker, J. M., Lanigan, C. M. S., Landucci, G., Forthal, D. N., Parren, P. W. H. I., et al. (2007) · Nature · doi:10.1038/nature06106 · Cited by 901
Self-citationBaba, T. W., Liska, V., Hofmann-Lehmann, R., Vlasak, J., Xu, W., Ayehunie, S., Cavacini, L. A., Posner, M. R., Katinger, H., Stiegler, G., et al. (2000) · Nature Medicine · doi:10.1038/72309 · Cited by 849
Mascola, J. R., Lewis, M. G., Stiegler, G., Harris, D., VanCott, T. C., Hayes, D., Louder, M. K., Brown, C. R., Sapan, C. V., Frankel, S. S., et al. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.4009-4018.1999 · Cited by 783
Antibody Domain Exchange Is an Immunological Solution to Carbohydrate Cluster Recognition
Calarese, D. A., Scanlan, C. N., Zwick, M. B., Deechongkit, S., Mimura, Y., Kunert, R., Zhu, P., Wormald, M. R., Stanfield, R. L., Roux, K. H., et al. (2003) · Science · doi:10.1126/science.1083182 · Cited by 781
Self-citationBinley, J. M., Wrin, T., Korber, B., Zwick, M. B., Wang, M., Chappey, C., Stiegler, G., Kunert, R., Zolla-Pazner, S., Katinger, H., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.23.13232-13252.2004 · Cited by 705
Self-citationScanlan, C. N., Pantophlet, R., Wormald, M. R., Saphire, E. O., Stanfield, R., Wilson, I. A., Katinger, H., Dwek, R. A., Rudd, P. M., & Burton, D. R. (2002) · Journal of Virology · doi:10.1128/jvi.76.14.7306-7321.2002 · Cited by 665
Self-citationParren, P. W. H. I., Marx, P. A., Hessell, A. J., Luckay, A., Harouse, J., Cheng-Mayer, C., Moore, J. P., & Burton, D. R. (2001) · Journal of Virology · doi:10.1128/jvi.75.17.8340-8347.2001 · Cited by 662
Self-citationSanders, R. W., Venturi, M., Schiffner, L., Kalyanaraman, R., Katinger, H., Lloyd, K. O., Kwong, P. D., & Moore, J. P. (2002) · Journal of Virology · doi:10.1128/jvi.76.14.7293-7305.2002 · Cited by 553
Shibata, R., Igarashi, T., Haigwood, N., Buckler–White, A., Ogert, R., Ross, W., Willey, R., Cho, M. W., & Martin, M. A. (1999) · Nature Medicine · doi:10.1038/5568 · Cited by 539
Progesterone implants enhance SIV vaginal transmission and early virus load
Marx, P. A., Spira, A. I., Gettie, A., Dailey, P. J., Veazey, R. S., Lackner, A. A., Mahoney, C. J., Miller, C. J., Claypool, L. E., Ho, D. D., et al. (1996) · Nature Medicine · doi:10.1038/nm1096-1084 · Cited by 465
Veazey, R. S., Shattock, R. J., Pope, M., Kirijan, J. C., Jones, J., Hu, Q., Ketas, T., Marx, P. A., Klasse, P. J., Burton, D. R., et al. (2003) · Nature Medicine · doi:10.1038/nm833 · Cited by 460
Self-citationSoilleux, E. J., Morris, L. S., Leslie, G., Chehimi, J., Luo, Q., Levroney, E., Trowsdale, J., Montaner, L. J., Doms, R. W., Weissman, D., et al. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.3.445 · Cited by 458
Roben, P., Moore, J. P., Thali, M., Sodroski, J., Barbas, C. F., & Burton, D. R. (1994) · Journal of Virology · doi:10.1128/jvi.68.8.4821-4828.1994 · Cited by 455
Self-citationChallenges in the development of an HIV-1 vaccine
Barouch, D. H. (2008) · Nature · doi:10.1038/nature07352 · Cited by 380
Nature of Nonfunctional Envelope Proteins on the Surface of Human Immunodeficiency Virus Type 1
Moore, P. L., Crooks, E. T., Porter, L., Zhu, P., Cayanan, C. S., Grise, H., Corcoran, P., Zwick, M. B., Franti, M., Morris, L., et al. (2006) · Journal of Virology · doi:10.1128/jvi.80.5.2515-2528.2006 · Cited by 343
Self-citationWalker, B. D., & Burton, D. R. (2008) · Science · doi:10.1126/science.1152622 · Cited by 338
Self-citationSattentau, Q. J., & Moore, J. P. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.1.185 · Cited by 334
Distinct Pathogenic Sequela in Rhesus Macaques Infected with CCR5 or CXCR4 Utilizing SHIVs
Harouse, J. M., Gettie, A., Tan, R. C. H., Blanchard, J., & Cheng-Mayer, C. (1999) · Science · doi:10.1126/science.284.5415.816 · Cited by 320
Dissection of the carbohydrate specificity of the broadly neutralizing anti-HIV-1 antibody 2G12
Calarese, D. A., Lee, H.-K., Huang, C.-Y., Best, M. D., Astronomo, R. D., Stanfield, R. L., Katinger, H., Burton, D. R., Wong, C.-H., & Wilson, I. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505763102 · Cited by 294
Self-citationWang, S.-K., Liang, P.-H., Astronomo, R. D., Hsu, T.-L., Hsieh, S.-L., Burton, D. R., & Wong, C.-H. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712326105 · Cited by 287
Self-citationMamu-B * 08 -Positive Macaques Control Simian Immunodeficiency Virus Replication
Loffredo, J. T., Maxwell, J., Qi, Y., Glidden, C. E., Borchardt, G. J., Soma, T., Bean, A. T., Beal, D. R., Wilson, N. A., Rehrauer, W. M., et al. (2007) · Journal of Virology · doi:10.1128/jvi.00895-07 · Cited by 286
Self-citationCasimiro, D. R., Wang, F., Schleif, W. A., Liang, X., Zhang, Z.-Q., Tobery, T. W., Davies, M.-E., McDermott, A. B., O'Connor, D. H., Fridman, A., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.24.15547-15555.2005 · Cited by 271
Self-citationGauduin, M.-C., Parren, P. W. H. I., Weir, R., Barbas, C. F., Burton, D. R., & Koup, R. A. (1997) · Nature Medicine · doi:10.1038/nm1297-1389 · Cited by 258
Self-citationAn HIV Vaccine — Evolving Concepts
Johnston, M. I., & Fauci, A. S. (2007) · New England Journal of Medicine · doi:10.1056/nejmra066267 · Cited by 257 · cited 1×
“There is widespread acceptance that eliciting neutralizing antibodies is likely to be an important goal of an effective HIV vaccine [1,2,3].”
BackgroundCryo-Electron Tomographic Structure of an Immunodeficiency Virus Envelope Complex In Situ
Zanetti, G., Briggs, J. A. G., Grünewald, K., Sattentau, Q. J., & Fuller, S. D. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020083 · Cited by 232
Subdominant CD8+T-Cell Responses Are Involved in Durable Control of AIDS Virus Replication
Friedrich, T. C., Valentine, L. E., Yant, L. J., Rakasz, E. G., Piaskowski, S. M., Furlott, J. R., Weisgrau, K. L., Burwitz, B., May, G. E., León, E. J., et al. (2007) · Journal of Virology · doi:10.1128/jvi.02392-06 · Cited by 220
Self-citationMothé, B. R., Weinfurter, J., Wang, C., Rehrauer, W., Wilson, N., Allen, T. M., Allison, D. B., & Watkins, D. I. (2003) · Journal of Virology · doi:10.1128/jvi.77.4.2736-2740.2003 · Cited by 208
Self-citationPoignard, P., Moulard, M., Golez, E., Vivona, V., Franti, M., Venturini, S., Wang, M., Parren, P. W. H. I., & Burton, D. R. (2003) · Journal of Virology · doi:10.1128/jvi.77.1.353-365.2003 · Cited by 188
Self-citationNishimura, Y., Igarashi, T., Haigwood, N., Sadjadpour, R., Plishka, R. J., Buckler-White, A., Shibata, R., & Martin, M. A. (2002) · Journal of Virology · doi:10.1128/jvi.76.5.2123-2130.2002 · Cited by 161
Parren, P. W. H. I., Ditzel, H. J., Gulizia, R. J., Binley, J. Μ., Barbas, C. F., Burton, D. R., & Mosier, D. E. (1995) · AIDS · doi:10.1097/00002030-199506000-00001 · Cited by 150
Self-citationAIDS virus envelope spike structure
Roux, K. H., & Taylor, K. A. (2007) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2007.03.008 · Cited by 103
Wolbank, S., Kunert, R., Stiegler, G. M., & Katinger, H. W. D. (2003) · Journal of Virology · doi:10.1128/jvi.77.7.4095-4103.2003 · Cited by 100
Lue, J., Hsu, M., Yang, D. C. H., Marx, P. A., Chen, Z., & Cheng‐Mayer, C. (2002) · Journal of Virology · doi:10.1128/jvi.76.20.10299-10306.2002 · Cited by 55
Identification of the Optimal DC-SIGN Binding Site on Human Immunodeficiency Virus Type 1 gp120
Hong, P. W.-P., Nguyen, S., Young, S., Su, S. V., & Lee, B. (2007) · Journal of Virology · doi:10.1128/jvi.01765-06 · Cited by 45
Binley, J. Μ., Ngo-Abdalla, S., Moore, P. L., Bobardt, M. D., Chatterji, U., Gallay, P. A., Burton, D. R., Wilson, I. A., Elder, J. H., & de Parseval, A. (2006) · Retrovirology · doi:10.1186/1742-4690-3-39 · Cited by 29
Self-citation
Cited by
Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target
Walker, L. M., Phogat, S. K., Chan-Hui, P.-Y., Wagner, D., Phung, P., Goss, J. L., Wrin, T., Simek, M. D., Fling, S., Mitcham, J. L., et al. (2009) · Science · doi:10.1126/science.1178746 · Cited by 1,723
Self-citationBroad neutralization coverage of HIV by multiple highly potent antibodies
Walker, L. M., Huber, M., Doores, K. J., Falkowska, E., Pejchal, R., Julien, J.-P., Wang, S.-K., Ramos, A., Chan-Hui, P.-Y., Moyle, M., et al. (2011) · Nature · doi:10.1038/nature10373 · Cited by 1,480
Self-citationThe immune response during acute HIV-1 infection: clues for vaccine development
McMichael, A. J., Borrow, P., Tomaras, G. D., Goonetilleke, N., & Haynes, B. F. (2010) · Nature Reviews Immunology · doi:10.1038/nri2674 · Cited by 871
Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design
Burton, D. R., & Hangartner, L. (2016) · Annual Review of Immunology · doi:10.1146/annurev-immunol-041015-055515 · Cited by 583
Self-citationComplex-type N -glycan recognition by potent broadly neutralizing HIV antibodies
Mouquet, H., Scharf, L., Euler, Z., Liu, Y., Eden, C., Scheid, J. F., Halper-Stromberg, A., Gnanapragasam, P. N. P., Spencer, D. I. R., Seaman, M. S., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1217207109 · Cited by 550
Metadata
- Authors
- Hessell, A. J., Rakasz, E. G., Poignard, P., Hangartner, L., Landucci, G., Forthal, D. N., Koff, W. C., Watkins, D. I., & Burton, D. R.
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-05-15
- Volume
- 5
- Issue
- 5
- Pages
- e1000433
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- OpenAlex
- W1990745725
- Cited by
- 497
- References
- 40
- FWCI
- 17.29
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.